The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...

At a public meeting held on January 15, 2025, the Federal Trade Commission (FTC) summarized the Second Interim Staff Report ...

A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, ...

The Federal Trade Commission on Jan. 14 published a second interim staff report on the prescription drug middleman industry, ...

A Wisconsin couple has filed a lawsuit against Minnesota-based Optum Rx and Walgreens for their son’s asthma-related death ...

Pharmacy Benefit Managers (PBM) sit in the center of our prescription drug system, coordinating between insurance companies, ...

The biggest pharmacy benefit managers have made efforts to improve relationships with pharmacies, health insurers, employers ...

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

Mintz’s Health Law and Antitrust teams actively monitor federal and state regulatory and legislative developments in the PBM ...

The two have mended fences after a nasty contract dispute in 2022 caused Kroger pharmacies to go out of network with Express ...

And though the stated goal of PBMs is to contain costs for patients, the FTC concluded they benefit from high rebates and ...

If California patients pay more than $35 per month for insulin now, it’s in large part because PBMs have rigged the system in ...